300439 Stock Overview
Medicalsystem Biotechnology Co., Ltd. provides clinical diagnostics reagents and instruments in China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Medicalsystem Biotechnology Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.65 |
| 52 Week High | CN¥12.60 |
| 52 Week Low | CN¥7.28 |
| Beta | 0.33 |
| 1 Month Change | 1.15% |
| 3 Month Change | -7.03% |
| 1 Year Change | -16.52% |
| 3 Year Change | -55.26% |
| 5 Year Change | -37.46% |
| Change since IPO | -26.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300439 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 9.3% | -1.6% | -0.4% |
| 1Y | -16.5% | -24.8% | -14.4% |
Return vs Industry: 300439 exceeded the CN Biotechs industry which returned -24.8% over the past year.
Return vs Market: 300439 underperformed the CN Market which returned -14.4% over the past year.
Price Volatility
| 300439 volatility | |
|---|---|
| 300439 Average Weekly Movement | 8.0% |
| Biotechs Industry Average Movement | 8.0% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300439 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300439's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 2,164 | Ji Hua Zou | www.nbmksw.com |
Medicalsystem Biotechnology Co., Ltd. provides clinical diagnostics reagents and instruments in China. The company offers PCR kit, antibody test kit, antigen and antibody test kit, and nucleic acid reagent for COVID-19; automated biochemistry analyzers and bio reagents; hematology analyzers and reagents; urine analyzers; glycated hemoglobin analyzer; blood lipid analyzer; microfluidic biochemical analyzer; POCT; and chemiluminescene immunoassay analyzers. It also provides healthcare services.
Medicalsystem Biotechnology Co., Ltd Fundamentals Summary
| 300439 fundamental statistics | |
|---|---|
| Market cap | CN¥3.71b |
| Earnings (TTM) | CN¥264.24m |
| Revenue (TTM) | CN¥1.88b |
14.0x
P/E Ratio2.0x
P/S RatioIs 300439 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300439 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.88b |
| Cost of Revenue | CN¥1.03b |
| Gross Profit | CN¥844.29m |
| Other Expenses | CN¥580.06m |
| Earnings | CN¥264.24m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.69 |
| Gross Margin | 44.99% |
| Net Profit Margin | 14.08% |
| Debt/Equity Ratio | 1.7% |
How did 300439 perform over the long term?
See historical performance and comparison